Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Central serous chorioretinopathy associated with testosterone therapy.

Ahad MA, Chua CN, Evans NM.

Eye (Lond). 2006 Apr;20(4):503-5. No abstract available.

PMID:
15846380
2.

The potential role of testosterone in central serous chorioretinopathy.

Grieshaber MC, Staub JJ, Flammer J.

Br J Ophthalmol. 2007 Jan;91(1):118-9. No abstract available.

3.

Central serous chorioretinopathy as a complication of postcardiac transplant corticosteroid therapy.

Singh AD, Demirci H, Shields CL, Shields JA.

Eye (Lond). 2003 May;17(4):522-4. No abstract available.

PMID:
12802354
4.

Central serous chorioretinopathy and glucocorticoids.

Bouzas EA, Karadimas P, Pournaras CJ.

Surv Ophthalmol. 2002 Sep-Oct;47(5):431-48. Review.

PMID:
12431693
5.

Central serous chorioretinopathy complicating systemic corticosteroid therapy.

Abu el-Asrar AM.

Eur J Ophthalmol. 1997 Jul-Sep;7(3):297-300.

PMID:
9352287
6.

Central serous chorioretinopathy associated with administration of sympathomimetic agents.

Michael JC, Pak J, Pulido J, de Venecia G.

Am J Ophthalmol. 2003 Jul;136(1):182-5.

PMID:
12834690
7.

Visual loss due to central serous chorioretinopathy during corticosteroid treatment for giant cell arteritis.

Bevis T, Ratnakaram R, Smith MF, Bhatti MT.

Clin Experiment Ophthalmol. 2005 Aug;33(4):437-9.

PMID:
16033370
8.

Central serous chorioretinopathy in patients receiving systemic corticosteroid therapy.

Levy J, Marcus M, Belfair N, Klemperer I, Lifshitz T.

Can J Ophthalmol. 2005 Apr;40(2):217-21. No abstract available.

PMID:
16049541
9.

Reversal of polycythaemia induced by intramuscular androgen replacement using transdermal testosterone therapy.

Siddique H, Smith JC, Corrall RJ.

Clin Endocrinol (Oxf). 2004 Jan;60(1):143-5. No abstract available.

PMID:
14678301
10.

An unusual case of central serous chorioretinopathy in a patient with acute retinal necrosis.

Stuebiger N, Biester S, Deuter CM, Zierhut M.

Ocul Immunol Inflamm. 2008 May-Jun;16(3):109-11. doi: 10.1080/09273940802056299.

PMID:
18569799
11.

The adverse effects of corticosteroids in central serous chorioretinopathy.

De Nijs E, Brabant P, De Laey JJ.

Bull Soc Belge Ophtalmol. 2003;(289):35-41.

PMID:
14619628
12.

Central serous chorioretinopathy in a patient using methylenedioxymethamphetamine (MDMA) or "ecstasy".

Hassan L, Carvalho C, Yannuzzi LA, Iida T, Negrão S.

Retina. 2001;21(5):559-61. No abstract available.

PMID:
11642397
13.

Central serous chorioretinopathy associated with topical dermal corticosteroids.

Fernandez CF, Mendoza AJ, Arevalo JF.

Retina. 2004 Jun;24(3):471-4. No abstract available.

PMID:
15187679
14.

Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies.

Jampol LM, Weinreb R, Yannuzzi L.

Ophthalmology. 2002 Oct;109(10):1765-6. Review. No abstract available.

PMID:
12359592
15.

Central serous chorioretinopathy and glucocorticoids.

Cusani M.

Surv Ophthalmol. 2004 Jan-Feb;49(1):128-9; author reply 129. No abstract available.

PMID:
14711450
16.

Central serous chorioretinopathy after inhaled steroid use for post-mycoplasmal bronchospasm.

Fardin B, Weissgold DJ.

Br J Ophthalmol. 2002 Sep;86(9):1065-6. No abstract available.

17.

Testosterone replacement in elderly men.

Baum NH, Crespi CA.

Geriatrics. 2007 Sep;62(9):15-8. Review.

PMID:
17824721
18.

Exacerbation of central serous chorioretinopathy following intravitreal triamcinolone injection.

Kocabora MS, Durmaz S, Kandemir N.

Graefes Arch Clin Exp Ophthalmol. 2008 Dec;246(12):1783-6. doi: 10.1007/s00417-008-0932-2. Epub 2008 Sep 3.

PMID:
18766364
19.

Risks of testosterone replacement.

Redmond G.

N Engl J Med. 2004 May 6;350(19):2004-6; author reply 2004-6. No abstract available.

PMID:
15131838
20.

Central serous chorioretinopathy in a patient taking sildenafil citrate.

Allibhai ZA, Gale JS, Sheidow TS.

Ophthalmic Surg Lasers Imaging. 2004 Mar-Apr;35(2):165-7.

PMID:
15088831
Items per page

Supplemental Content

Write to the Help Desk